Ali Nouruddin W, Abdelwahab Nada S, Abdelkawy M, Emam Aml A
Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Beni-Suef University, Al shaheed Shehata Ahmed Hegazy st., 62514 Beni-Suef, Egypt.
Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Beni-Suef University, Al shaheed Shehata Ahmed Hegazy st., 62514 Beni-Suef, Egypt.
Spectrochim Acta A Mol Biomol Spectrosc. 2016 Feb 5;154:114-122. doi: 10.1016/j.saa.2015.10.037. Epub 2015 Oct 24.
A pharmaceutically marketed mixture of Yohimbine, Alpha-tocopheryl acetate, Niacin, and Caffeine co-formulated as a promising therapy for erectile dysfunction. Simultaneous determination of the aforementioned pharmaceutical formulation without prior separation steps was applied using mean centering of ratio spectra and triple divisor spectrophotometric methods. Mean centering of ratio spectra method depended on using the mean centered ratio spectra in three successive steps which eliminated the derivative steps and so the signal to noise ratio was improved. The absorption spectra of the prepared solutions were measured in the wavelength range of 215-300 nm in the concentration ranges of 1-15, 3-15, 1-20, and 3-15 μg mL(-1) for Yohimbine, Alpha-tocopheryl acetate, Niacin, and Caffeine, respectively. The amplitudes of the mean centered third ratio spectra were measured at 250 nm and 268 nm for Yohimbine and Alpha-tocopheryl acetate, respectively and at peak to peak 272-273 and 262-263 nm for Niacin and Caffeine, respectively. In triple divisor method each drug in the quaternary mixture was determined by dividing the spectrum of the quaternary mixture by a standard spectrum of a mixture containing equal concentrations of the other three drugs. First derivative of these ratio spectra was obtained where determination could be achieved without any interference from the other three drugs. Amplitudes of 1-15, 3-15, 1-15, and 3-15 μg mL(-1) were used for selective determination of Yohimbine, Alpha-tocopheryl acetate, Niacin, and Caffeine, respectively. Laboratory prepared mixtures were analyzed by the developed novel methods to investigate their selectivity also, Super Act® capsules were successfully analyzed to ensure absence of interference from additives. The developed methods were validated according to the ICH guidelines. The proposed methods were statistically compared with each other and with the reported methods; using student t-test, F-test, and one way ANOVA, where no significant difference was found with respect to accuracy and precision.
育亨宾、醋酸α-生育酚、烟酸和咖啡因的一种药物上市混合物,共同配制作为一种有前景的勃起功能障碍治疗方法。采用比率光谱均值中心化和三除数分光光度法,无需事先分离步骤即可同时测定上述药物制剂。比率光谱均值中心化方法依赖于在三个连续步骤中使用均值中心化比率光谱,这消除了求导步骤,从而提高了信噪比。所制备溶液的吸收光谱在215 - 300 nm波长范围内测量,育亨宾、醋酸α-生育酚、烟酸和咖啡因的浓度范围分别为1 - 15、3 - 15、1 - 20和3 - 15 μg mL(-1)。育亨宾和醋酸α-生育酚的均值中心化第三比率光谱的幅值分别在250 nm和268 nm处测量,烟酸和咖啡因的幅值分别在峰峰值272 - 273 nm和262 - 263 nm处测量。在三除数法中,通过将四元混合物的光谱除以含有其他三种药物等浓度的混合物的标准光谱来测定四元混合物中的每种药物。获得这些比率光谱的一阶导数,从而可以在不受其他三种药物干扰的情况下进行测定。分别使用1 - 15、3 - 15、1 - 15和3 - 15 μg mL(-1)的幅值来选择性测定育亨宾、醋酸α-生育酚、烟酸和咖啡因。还通过所开发的新方法对实验室制备的混合物进行分析以研究其选择性,成功分析了Super Act®胶囊以确保不存在添加剂的干扰。所开发的方法根据ICH指南进行了验证。对所提出的方法进行相互之间以及与已报道方法的统计学比较;使用学生t检验、F检验和单因素方差分析,结果在准确性和精密度方面未发现显著差异。